Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 8 , ISSUE 1 ( January-March, 2016 ) > List of Articles


A Prospective Study to study the Efficacy and Side Effects of Ormeloxifene in Regression of Mastalgia and Fibroadenoma: Is It the Ideal Drug?

Nidhi Gupta

Citation Information : Gupta N. A Prospective Study to study the Efficacy and Side Effects of Ormeloxifene in Regression of Mastalgia and Fibroadenoma: Is It the Ideal Drug?. J South Asian Feder Obs Gynae 2016; 8 (1):48-56.

DOI: 10.5005/jp-journals-10006-1385

Published Online: 01-06-2013

Copyright Statement:  Copyright © 2016; The Author(s).


PDF Share
  1. Clinical evaluation of Centchroman: a new oral contraceptive. In: Puri CP, VanLook PFa, editors. Hormone antagonists for fertility regulation. Ind Soc Study Reprod Fert, India, Bombay, 1998. p. 223-230.
  2. Centchroman regresses mastalgia: A randomised comparison with Danazol. Ind J Surg 2011 May-Jun;73930:199-205.
  3. Role of centchroman in regression of mastalgia and fibroadenoma. World J Surg 2007;31:1178-1184.
  4. Cyclical mastalgia—is it a manifestation of aberration in lipid metabolism? Ind J Physiol Pharmacol 1994;38:267-271.
  5. Treatment of cyclical mastalgia: results of a randomized, placebo-controlled, double-blind study [translated from German]. Geburtsh Frauenheilk 1997;57:569-574.
  6. Treatment of mastopathy associated with cyclic mastodynia: clinical results and hormone profiles [translated from German]. Gynakol Rundsch 1986;26:65-79.
  7. Prolactin response to thyrotropin-releasing hormone stimulat ion and dopaminergic inhibition in benign breast disease. Cancer 1984;53:1311-1315.
  8. Behaviour of estrogen receptor, histological correlation, and clinical outcome in patients with benign breast disorders. Eur J Surg 2002;168:631-634.
  9. Plasma oestradiol and progesterone in benign breast disease. Eur J Cancer 1973;9:553-556.
  10. Breast pain nodularity. In: Hughes LE, Mansell RE, Webster DJT. Benign Disorders and diseases of the breast: concepts and clinical management. 2nd ed. London: WB Saunders Company; 2000. p. 95-121.
  11. Diagnosis of diseases of the breast. 1st ed. Philadelphia: WB Saunders Company; 1997. p. 385.
  12. Twenty-fourhour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res 1977;37:4655-4659.
  13. Serum prolactin concentration on benign breast disease throughout the menstrual cycle. Eur J Cancer 1977;13:597-603.
  14. PRL, TSH and thyroid hormones in benign breast disease. Klin Wochenschr 1981;59:403-407.
  15. Reassurance in the treatment of mastalgia. Breast J 1999;5:162-165.
  16. Sports brassiere: is it a solution for mastalgia? Breast J 2000;6:407-409.
  17. Effects of caffeine free diet on benign breast disease: a randomized trial. Surgery 1982;91:263-267.
  18. Response of fibrocystic disease to caffeine withdrawal and correlation with cyclic nucleotides with breast disease. Am J Obstet Gynecol 1979;135:157
  19. Oral contraceptives and reduced risk of benign breast diseases. N Engl J Med 1976;294:419-422.
  20. A case control study of diet and benign proliferative epithelial disorder of the breast. Cancer Res 1990;50:3176-3181.
  21. A clinical trial of evening primrose oil in mastalgia. Br J Surg 1981;68:801
  22. Evening primrose oil and fish oil for severe chronic mastalgia: a randomized, double blind, controlled trial. Am J Obstet Gynecol 2002;187:1389-1394.
  23. Effect of evening primrose oil on clinically diagnosed fibroadenomas. Breast 2000;9:35-36.
  24. Vitamin E and evening primrose oil for management of cyclical mastalgia: a randomized pilot study. Altern Med Rev 2010;15(1): 59-67.
  25. A double-blind randomized controlled trial of isoflavones in the treatment of cyclical mastalgia. The Breast 2002;11:170-174.
  26. Abnormalities in plasma essential fatty acid levels in women with premenstrual syndrome and with nonmalignant breast disease. J Nutr Med 1991;2:259-264.
  27. Effects and tolerability of n-6 essential fatty acid supplementation in patients with recurrent breast cysts—a randomized doubleblind placebo-controlled trial. J Nutr Med 1990;1:195-200.
  28. Behaviour of estrogen receptor, histological correlation and clinical outcome in patients with benign breast disorder. Eur J Surg 2002;168:631
  29. On behalf of the Efamast study group: a randomized multicenter study of gamolenic acid (Efamast) with and without antioxidant vitamins and minerals in the management of mastalgia. Breast J 2005;11:41-47.
  30. Aberration of normal development and involution: a new perspective on pathogenesis and nomenclature of benign breast disorders. Lancet 1987;11:1316-1319.
  31. Clinical studies with an antigonadotrophin-Danazol. Fertil Steril 1971;22:102-112.
  32. The use of an impeded androgen Danazol in the management of benign breast disorders. Am J Obstet Gynecol 1971;127:130-134.
  33. Maintenance therapy of cyclical mastalgia using low dose Danazol. J R Coll Surg Edinb 1989;34:79-84.
  34. A doubleblind controlled trial of danazol and bromocriptine in the management of severe cyclical breast pain. Br J Clin Pract 1986;40:326-330.
  35. A review of the role of bromocriptine in symptomatic benign breast disease. Res Clin Forum 1981;3:61-63.
  36. Evaluation of the ultrasonographic volume of breast fibroadenomas in women treated with tamoxifen. Minerva Gynecol 2002;54 (6):531-535.
  37. Dosage and duration of tamoxifen for mastalgia: a controlled trial. Br J Surg 1988;75:845-846.
  38. Effect of some non-steroidal antifertility agents on the biochemistry of the uterus and uterine fluids in rats.indian J Exp Biol 1973;11:479-483.
  39. Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet 1986;8376:287-288.
  40. European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia. Am J Obstet Gynecol 2004;191:1942-1949.
  41. Risk factor for fibroadenoma: a case control study in Australia. Am J Epidemiol 1992;135:247-258.
  42. An epidemiologic study of breast cancer and benign breast neoplasm in relation to the oral contraceptive and estrogen use. Eur J Cancer 1979;15:395-405.
  43. Fibroadenoma and the use of exogenous hormones: a case control study. Am J Epidemiol 1988;127:454-461.
  44. Evaluation of the ultrasonographic volume of breast fibroadenomas in women treated with tamoxifen. Minerva Gynecol 2002;54: 531-535.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.